Vir Biotechnology, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
VIR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1800 Owens Street, Suite 900, San Francisco, California

Insiders trading volume in the past year

Vir Biotechnology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
SVF Endurance (Cayman) Ltd 10%+ Owner $25.5M Jun 30, 2023
Vicki L. Sato Director $12.5M May 30, 2024
Marianne De Backer Chief Executive Officer, Director $7.96M -$690K -7.98% Jun 12, 2024
Robert Nelsen Director $5.87M May 30, 2024
Robert J. More Director $5.16M May 30, 2024
George A. Scangos Director $2.87M -$591K -17.1% May 30, 2024
Phillip Pang EVP & Chief Medical Officer $2.51M -$180K -6.7% Feb 22, 2024
Ann M. Hanly EVP & Chief Technology Officer $1.43M -$151K -9.56% Apr 1, 2024
Sung Lee EVP & Chief Financial Officer $1.12M -$59.4K -5.05% Mar 27, 2024
Mark Eisner EVP and Chief Medical Officer $1.05M Jul 15, 2024
Herbert Virgin EVP, Research & CSO $594K Aug 9, 2022
Howard Horn Cfo $353K Feb 23, 2023
Charles Elliott Sigal Director $344K May 30, 2024
Phillip A. Sharp Director $272K May 22, 2023
Jeffrey S. Hatfield Director $250K May 30, 2024
Johanna Friedl-Naderer EVP & Chief Operating Officer $227K Mar 3, 2023
Saira Ramasastry Director $185K -$43.8K -19.2% Jun 11, 2024
Norbert W. Bischofberger Director $176K May 29, 2024
Ramy Farid Director $176K May 29, 2024
Steven J. Rice Chief Administrative Officer $163K Jun 1, 2023
ARCH Venture Partners IX, LLC 10%+ Owner $140K Sep 2, 2022
Janet Napolitano Director $115K -$95K -45.2% Sep 9, 2024
Robert Perez Director $42.6K May 22, 2023
Dipchand Nishar Director $15.5K May 21, 2021

Recent Insider Transactions by Companies or Individuals for Vir Biotechnology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.